General Information of Drug (ID: DMSE3I7)

Drug Name
Gemcitabine Drug Info
Synonyms
Gemcitabine hydrochloride; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabinum; Gemtro; Gemzar; Zefei; Gemcitabine HCl; Gemcitabine stereoisomer; LY 188011; LY188011; Gemcitabina [INN-Spanish]; Gemcitabinum [INN-Latin]; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY-188011; Gemcitabine (USAN/INN)
Indication
Disease Entry ICD 11 Status REF
Anterior urethra cancer Approved [1]
Biliary tract cancer 2C17 Approved [1]
Carcinoma 2A00-2F9Z Approved [1]
Cervical cancer 2C77.0 Approved [1]
Cholangiocarcinoma 2C12.10 Approved [1]
Fallopian tube neoplasm Approved [1]
Gallbladder carcinoma Approved [1]
Leiomyosarcoma 2B58 Approved [1]
Leukemia Approved [1]
Lung cancer 2C25.0 Approved [1]
MALT lymphoma Approved [1]
Nodal marginal zone lymphoma 2A85.0 Approved [1]
Non-small-cell lung cancer 2C25 Approved [2]
Ovarian disorder Approved [1]
Ovarian neoplasm Approved [1]
Pancreatic adenocarcinoma Approved [1]
Pancreatic ductal carcinoma 2C10.0 Approved [1]
Pancreatic tumour 2C10 Approved [1]
Posterior urethra cancer Approved [1]
Recurrent adult burkitt lymphoma 2A85.6 Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [3]
Splenic marginal zone lymphoma Approved [1]
Urethral cancer 2C93 Approved [1]
Urinary bladder neoplasm Approved [1]
Middle East Respiratory Syndrome (MERS) 1D64 Preclinical [4]
Severe acute respiratory syndrome (SARS) 1D65 Preclinical [4]
Colon cancer 2B90.Z Investigative [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
60750
ChEBI ID
CHEMBL175901
CAS Number
CAS 95058-81-4
TTD Drug ID
DMSE3I7
VARIDT Drug ID
DR00063
INTEDE Drug ID
DR0765

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [5]
CO-101 DMH5GQU Pancreatic cancer 2C10 Phase 2 [17]
Triapine DM7XZY5 Nerve injury ND56.4 Phase 2 [18]
CALAA-01 DMT4Z5B Solid tumour/cancer 2A00-2F9Z Phase 1 [19]
LY-2334737 DMCBV20 Solid tumour/cancer 2A00-2F9Z Phase 1 [20]
Gallium maltolate DMX0Z51 Human immunodeficiency virus infection 1C62 Discontinued in Phase 2 [21]
MDL 101,731 DMKEYSX Gastric adenocarcinoma 2B72 Discontinued in Phase 2 [22]
NKP-46 DMK8UD0 Solid tumour/cancer 2A00-2F9Z Preclinical [23]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Transported By P-glycoprotein 1 (ABCB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [24]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [25]
Methotrexate DM2TEOL Anterior urethra cancer Approved [26]
Folic Acid DMEMBJC Colorectal carcinoma Approved [27]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [26]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [26]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [28]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [26]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [29]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [30]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [31]
Folic Acid DMEMBJC Colorectal carcinoma Approved [31]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [32]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [33]
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [34]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [35]
FLUORESCEIN DMQTFAO Ocular disease 1F00.1Z Approved [36]
Pemetrexed DMMX2E6 Central nervous system lymphoma 2B33.5 Approved [37]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [38]
[3H]cAMP DMZRQU7 Discovery agent N.A. Investigative [39]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [40]
Uridine DMQTREB Depression 6A70-6A7Z Approved [41]
Trifluridine DMG2YBD Herpetic keratitis 1F00.10 Approved [42]
Drug(s) Metabolized By Cytidine aminohydrolase (CDA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [43]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [44]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [45]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [46]
Drug(s) Metabolized By Cytidine deaminase (cdd)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [12]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [12]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [12]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [47]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [48]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [49]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [50]
Cepharanthine DM9Y5JB N. A. N. A. Approved [51]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [52]
Clozapine DMFC71L Schizophrenia 6A20 Approved [53]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [54]
Trifluoperazine DMKBYWI Anxiety Approved [55]
Olanzapine DMPFN6Y Bipolar depression Approved [53]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [56]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [64]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [56]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [61]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [64]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
⏷ Show the Full List of 20 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [66]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [68]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [69]
Selenium DM25CGV N. A. N. A. Approved [70]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [66]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [71]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [71]
Quercetin DM3NC4M Obesity 5B81 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Methotrexate DM2TEOL Anterior urethra cancer Approved [74]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [75]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [76]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Bortezomib DMNO38U Leukemia Approved [77]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [79]
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [80]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [81]
Methotrexate DM2TEOL Anterior urethra cancer Approved [82]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [84]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stearoyl-CoA desaturase (SCD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clavulanate DM2FGRT Bacteremia 1A73 Approved [88]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [89]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [89]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [91]
Fluoxetine DM3PD2C Bipolar depression Approved [89]
Fructose DM43AN2 Vomiting MD90 Approved [92]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [93]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [89]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [94]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [98]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [100]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [101]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [103]
Fluoxetine DM3PD2C Bipolar depression Approved [104]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [105]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [106]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [107]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [108]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [110]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Indomethacin DMSC4A7 Bursitis Approved [113]
Urethane DM7NSI0 N. A. N. A. Phase 4 [114]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [115]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [116]
Milchsaure DM462BT Pruritus EC90 Investigative [117]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [85]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [120]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [121]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [122]
Quercetin DM3NC4M Obesity 5B81 Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [124]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [125]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [126]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [127]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [129]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [130]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [131]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Selenium DM25CGV N. A. N. A. Approved [94]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [133]
Testosterone enanthate DMB6871 N. A. N. A. Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Ethanol DMDRQZU Chronic pain MG30 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [138]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [139]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [140]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [141]
Drug(s) Affected By Liprin-alpha-4 (PPFIA4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ethanol DMDRQZU Chronic pain MG30 Approved [142]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [98]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [146]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Maf (MAF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [149]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [150]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [151]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [153]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [154]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [69]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [157]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [158]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [159]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Krueppel-like factor 8 (KLF8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [160]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [138]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [128]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Fibrinogen gamma chain (FGG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [163]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [164]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [165]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [166]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [167]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [163]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [168]
Selenium DM25CGV N. A. N. A. Approved [94]
Methotrexate DM2TEOL Anterior urethra cancer Approved [169]
Quercetin DM3NC4M Obesity 5B81 Approved [170]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [171]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [172]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [174]
Selenium DM25CGV N. A. N. A. Approved [175]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [91]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [176]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [176]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [157]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [179]
Testosterone DM7HUNW Hot flushes GA30 Approved [180]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [181]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [182]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Quercetin DM3NC4M Obesity 5B81 Approved [183]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [184]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [185]
Estrone DM5T6US Acne vulgaris ED80 Approved [182]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [186]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [187]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [188]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [189]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [190]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [191]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [190]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [190]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Fluoxetine DM3PD2C Bipolar depression Approved [190]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [192]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Creatine kinase B-type (CKB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [79]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Selenium DM25CGV N. A. N. A. Approved [94]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [176]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [176]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [193]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [194]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-1 (CDH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [168]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [195]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [196]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [197]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [198]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [199]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [200]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [160]
Folic Acid DMEMBJC Colorectal carcinoma Approved [201]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
Topotecan DMP6G8T Central nervous system neoplasm Approved [139]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [203]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [204]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [205]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [206]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [207]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [208]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [209]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [210]
Dacarbazine DMNPZL4 Adenocarcinoma 2D40 Approved [211]
Topotecan DMP6G8T Central nervous system neoplasm Approved [212]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [213]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [215]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [100]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [216]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Methotrexate DM2TEOL Anterior urethra cancer Approved [74]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [216]
Ethacrynic acid DM60QMR Edema MG29 Approved [217]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [218]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [219]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [216]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Selenium DM25CGV N. A. N. A. Approved [94]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [220]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [93]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [221]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [221]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [222]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [223]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [194]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [224]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [222]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein EVI2B (EVI2B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [185]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [185]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [138]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [226]
Testosterone undecanoate DMZO10Y Hypogonadism 5A61.0 Approved [227]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [228]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [229]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [119]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [230]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [231]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [232]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [233]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [234]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Isoproterenol DMK7MEY Atrioventricular block Approved [235]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Teriflunomide DMQ2FKJ Hyperlipidaemia 5C80 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [237]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [238]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [239]
Gefitinib DM15F0X Colon adenocarcinoma Approved [240]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [241]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [163]
Etretinate DM2CZFA Keratosis ED56 Approved [242]
Prednisone DM2HG4X Acute asthma CA23 Approved [243]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [244]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [66]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [245]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [246]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [247]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [56]
Quercetin DM3NC4M Obesity 5B81 Approved [249]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [250]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [251]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Folic Acid DMEMBJC Colorectal carcinoma Approved [201]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [252]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [253]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [254]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [110]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [110]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [255]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [110]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [110]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [110]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [256]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [257]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [259]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [98]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [205]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [205]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [260]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [262]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Folic Acid DMEMBJC Colorectal carcinoma Approved [201]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [254]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [157]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [263]
Arsenic DMTL2Y1 N. A. N. A. Approved [264]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [265]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [266]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [267]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [268]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [269]
Quercetin DM3NC4M Obesity 5B81 Approved [270]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [271]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [272]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [255]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [273]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [274]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [275]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [277]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [278]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [247]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Aluminium DM6ECN9 Hyperhidrosis EE00 Approved [280]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [281]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Urethane DM7NSI0 N. A. N. A. Phase 4 [114]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [282]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [283]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H4 (H4C1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [163]
Selenium DM25CGV N. A. N. A. Approved [94]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [284]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Panobinostat DM58WKG Chronic graft versus host disease Approved [285]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 20 (CCL20)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [213]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [174]
Methotrexate DM2TEOL Anterior urethra cancer Approved [177]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [286]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [287]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [154]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [289]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [290]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [291]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [292]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [130]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [218]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [87]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [130]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [293]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [294]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [295]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [296]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [298]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Bortezomib DMNO38U Leukemia Approved [299]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [300]
Chondroitin sulfate DM0N19Y N. A. N. A. Phase 4 [301]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [302]
Calcidiol DMN4CV5 Hypophosphatemia Approved [303]
Calcipotriol DM03CP7 Psoriasis EA90 Approved [304]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [305]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [306]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [307]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [308]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [309]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [56]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [166]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [101]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [311]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [273]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Benzatropine DMF7EXL Parkinsonian disorder Approved [312]
Clozapine DMFC71L Schizophrenia 6A20 Approved [312]
Urethane DM7NSI0 N. A. N. A. Phase 4 [114]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [313]
PP-242 DM2348V Discovery agent N.A. Investigative [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [116]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [315]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [316]
Arsenic DMTL2Y1 N. A. N. A. Approved [317]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [318]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ankyrin-3 (ANK3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [168]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [319]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Testosterone enanthate DMB6871 N. A. N. A. Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [257]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [320]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [321]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
Folic Acid DMEMBJC Colorectal carcinoma Approved [322]
Menthol DMG2KW7 Back pain ME84.Z Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [85]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [279]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Treacle protein (TCOF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [312]
Quercetin DM3NC4M Obesity 5B81 Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [306]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Testosterone enanthate DMB6871 N. A. N. A. Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [325]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [326]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [327]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [328]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [219]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [325]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [326]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [329]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [330]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [125]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [331]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [332]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [219]
Etodolac DM6WJO9 Osteoarthritis FA00-FA05 Approved [333]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [334]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Selenium DM25CGV N. A. N. A. Approved [94]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [335]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [336]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [337]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [338]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [339]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Raltitrexed DMT9K8G Rectal adenocarcinoma 2B92 Approved [339]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [152]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [339]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ethanol DMDRQZU Chronic pain MG30 Approved [340]
Folic Acid DMEMBJC Colorectal carcinoma Approved [341]
Ampicillin DMHWE7P Acute epiglottitis Approved [58]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Disks large homolog 2 (DLG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [312]
Haloperidol DM96SE0 Delirium Approved [312]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [298]
Benzatropine DMF7EXL Parkinsonian disorder Approved [312]
Clozapine DMFC71L Schizophrenia 6A20 Approved [312]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [342]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [149]
Urethane DM7NSI0 N. A. N. A. Phase 4 [114]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [343]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [157]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-G2 (CCNG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [182]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Fluoxetine DM3PD2C Bipolar depression Approved [328]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Estrone DM5T6US Acne vulgaris ED80 Approved [182]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [110]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [110]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [157]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [344]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [93]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [265]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [93]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [338]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [345]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [346]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [202]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [347]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [348]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [349]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [306]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Bortezomib DMNO38U Leukemia Approved [299]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [177]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [350]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [351]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [352]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
Milchsaure DM462BT Pruritus EC90 Investigative [117]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [353]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By F-box only protein 25 (FBXO25)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [203]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [354]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [189]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [355]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Testosterone enanthate DMB6871 N. A. N. A. Approved [134]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [356]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Vandetanib DMRICNP Solid tumour/cancer 2A00-2F9Z Approved [357]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [279]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [252]
Methotrexate DM2TEOL Anterior urethra cancer Approved [177]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [160]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [100]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [177]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [263]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By La-related protein 4B (LARP4B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [94]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [358]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [336]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [359]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [139]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [94]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [360]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [345]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [345]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [107]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [319]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Ethanol DMDRQZU Chronic pain MG30 Approved [340]
Benzatropine DMF7EXL Parkinsonian disorder Approved [312]
Clozapine DMFC71L Schizophrenia 6A20 Approved [312]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [361]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [300]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sialidase-1 (NEU1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [284]
Fluoxetine DM3PD2C Bipolar depression Approved [104]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Panobinostat DM58WKG Chronic graft versus host disease Approved [256]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [336]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [265]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [152]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [138]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
Fenretinide DMRD5SP Macular degeneration 9B78.3 Phase 3 [362]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [98]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [363]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
Urethane DM7NSI0 N. A. N. A. Phase 4 [114]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [364]
Methyl Mercury Ion DM6YEW4 Discovery agent N.A. Investigative [364]
Tributylstannanyl DMHN7CB Discovery agent N.A. Investigative [364]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Folic Acid DMEMBJC Colorectal carcinoma Approved [201]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [365]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [366]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [367]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [368]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [177]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [177]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [344]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Capsaicin DMGMF6V Back pain ME84.Z Approved [369]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [345]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [352]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [153]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [103]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [66]
Methotrexate DM2TEOL Anterior urethra cancer Approved [370]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [371]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [130]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [372]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Intersectin-2 (ITSN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [373]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [300]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [366]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Urethane DM7NSI0 N. A. N. A. Phase 4 [114]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [265]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
Torcetrapib DMDHYM7 Hyperlipidaemia 5C80 Discontinued in Phase 2 [374]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [354]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [375]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [376]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [377]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [366]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [148]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [378]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [153]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Testosterone enanthate DMB6871 N. A. N. A. Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Clozapine DMFC71L Schizophrenia 6A20 Approved [312]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Alpha-2-macroglobulin (A2M)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [379]
Prednisone DM2HG4X Acute asthma CA23 Approved [380]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [193]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [107]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [193]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [381]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Aminocaproic Acid DMFGND4 Bleeding disorder GA20-GA21 Approved [380]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stromelysin-1 (MMP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [252]
Fluvastatin DM4MDJY Arteriosclerosis BD40 Approved [252]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [252]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [252]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [174]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [382]
Methotrexate DM2TEOL Anterior urethra cancer Approved [383]
Quercetin DM3NC4M Obesity 5B81 Approved [384]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [385]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-8 (CXCL8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [386]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [387]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [388]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [389]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [390]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [213]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [391]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [392]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [393]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [391]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 3 (CCL3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [394]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [232]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [233]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [395]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [343]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [396]
Betamethasone DMAHJEF Acute adrenal insufficiency Approved [397]
Emetine DMCT2YF Hepatitis virus infection 1E50-1E51 Approved [397]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 2 (CCL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [394]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [79]
Gefitinib DM15F0X Colon adenocarcinoma Approved [398]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [399]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [400]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [179]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [401]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [402]
Quercetin DM3NC4M Obesity 5B81 Approved [403]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kit ligand (KITLG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [294]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Quercetin DM3NC4M Obesity 5B81 Approved [404]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [319]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [405]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [377]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By CD40 ligand (CD40LG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [399]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [223]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [406]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [407]
Asasantin DMCZIHT Cerebrovascular ischaemia 8B1Z Approved [408]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [409]
Menthol DMG2KW7 Back pain ME84.Z Approved [323]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [410]
Eptifibatide DMQXTJS Acute cardiac ischemic events BA40.Z Approved [411]
Candesartan DMRK8OT Chronic heart failure BD1Z Approved [409]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pappalysin-1 (PAPPA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [160]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [279]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [100]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [412]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [413]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pro-interleukin-16 (IL16)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [414]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ethanol DMDRQZU Chronic pain MG30 Approved [415]
Menthol DMG2KW7 Back pain ME84.Z Approved [323]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [416]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [263]
Arsenic DMTL2Y1 N. A. N. A. Approved [417]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [418]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [419]
Propranolol DM79NTF Angina pectoris BA40 Approved [420]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [421]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [422]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Mebendazole DMO14SG Ascariasis 1F62 Approved [423]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [424]
Gefitinib DM15F0X Colon adenocarcinoma Approved [240]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [425]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [327]
Etretinate DM2CZFA Keratosis ED56 Approved [242]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [284]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [426]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [427]
Quercetin DM3NC4M Obesity 5B81 Approved [428]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [429]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nuclear protein 1 (NUPR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [190]
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [430]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [191]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [190]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [190]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Fluoxetine DM3PD2C Bipolar depression Approved [190]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [306]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [430]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [252]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [431]
Diazepam DM08E9O Alcohol withdrawal Approved [432]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [168]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [433]
Methotrexate DM2TEOL Anterior urethra cancer Approved [370]
Ceruletide DM2WE5K Caerulein stimulated gastric and pancreatic secretion 5A4Y Approved [434]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [435]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [436]
Quercetin DM3NC4M Obesity 5B81 Approved [437]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 1 (PARP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Gefitinib DM15F0X Colon adenocarcinoma Approved [438]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [439]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [327]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [440]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [244]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [440]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [441]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [442]
Methotrexate DM2TEOL Anterior urethra cancer Approved [443]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [94]
Quercetin DM3NC4M Obesity 5B81 Approved [444]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Vismodegib DM5IXKQ Basal cell carcinoma 2C32 Approved [445]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [446]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [100]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [447]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By CD44 antigen (CD44)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [182]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Selenium DM25CGV N. A. N. A. Approved [448]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [449]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [450]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [93]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [451]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [331]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H2AX (H2AX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [452]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [453]
Selenium DM25CGV N. A. N. A. Approved [94]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [454]
Etretinate DM2CZFA Keratosis ED56 Approved [455]
Methotrexate DM2TEOL Anterior urethra cancer Approved [456]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [457]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [458]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [459]
Quercetin DM3NC4M Obesity 5B81 Approved [460]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [168]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [163]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [327]
Methotrexate DM2TEOL Anterior urethra cancer Approved [461]
Epinephrine DM3KJBC Acute asthma CA23 Approved [462]
Quercetin DM3NC4M Obesity 5B81 Approved [463]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [464]
Fructose DM43AN2 Vomiting MD90 Approved [465]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [328]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [466]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [467]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [468]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [469]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [470]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [471]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [472]
Gefitinib DM15F0X Colon adenocarcinoma Approved [473]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [474]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [475]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [476]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Quercetin DM3NC4M Obesity 5B81 Approved [477]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [478]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [479]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [361]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [361]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [480]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [467]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [481]
Paclitaxel DMLB81S Breast carcinoma Approved [482]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [483]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [466]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [252]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [469]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [470]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By 14-3-3 protein sigma (SFN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [294]
Gefitinib DM15F0X Colon adenocarcinoma Approved [484]
Methotrexate DM2TEOL Anterior urethra cancer Approved [370]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [295]
Quercetin DM3NC4M Obesity 5B81 Approved [485]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [295]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [486]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [487]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catenin beta-1 (CTNNB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [488]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [489]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [490]
Quercetin DM3NC4M Obesity 5B81 Approved [463]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [491]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [492]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [493]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [494]
Testosterone DM7HUNW Hot flushes GA30 Approved [495]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [496]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [497]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [498]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [499]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
Quercetin DM3NC4M Obesity 5B81 Approved [270]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [500]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [93]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [94]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [289]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [501]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Methotrexate DM2TEOL Anterior urethra cancer Approved [502]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [254]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [247]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [501]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [294]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [163]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [59]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [306]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [503]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [327]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [404]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [95]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [504]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [505]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [506]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [449]
Quercetin DM3NC4M Obesity 5B81 Approved [507]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [192]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [331]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [508]
Testosterone DM7HUNW Hot flushes GA30 Approved [509]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [510]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [511]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [67]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [512]
Selenium DM25CGV N. A. N. A. Approved [94]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [499]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [513]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [514]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [515]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [93]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [516]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [279]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Ethanol DMDRQZU Chronic pain MG30 Approved [252]
Drug(s) Affected By Bcl-2-like protein 1 (BCL2L1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [267]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [517]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [327]
Selenium DM25CGV N. A. N. A. Approved [94]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [518]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [519]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [329]
Quercetin DM3NC4M Obesity 5B81 Approved [404]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [232]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [79]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Vismodegib DM5IXKQ Basal cell carcinoma 2C32 Approved [445]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [446]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [96]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ethanol DMDRQZU Chronic pain MG30 Approved [520]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [521]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sonic hedgehog protein (SHH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [444]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [522]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [446]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [523]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Folic Acid DMEMBJC Colorectal carcinoma Approved [201]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [522]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [300]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [524]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [57]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [372]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [110]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [110]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein smoothened (SMO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Quercetin DM3NC4M Obesity 5B81 Approved [444]
Vismodegib DM5IXKQ Basal cell carcinoma 2C32 Approved [445]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [525]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [100]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein NANOG (NANOG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [526]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [449]
Quercetin DM3NC4M Obesity 5B81 Approved [507]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [192]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [331]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [508]
Testosterone DM7HUNW Hot flushes GA30 Approved [509]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [527]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Axin-2 (AXIN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [289]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [528]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [529]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [530]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [531]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [128]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [60]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [532]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Splicing factor 45 (RBM17)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [312]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [533]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [57]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [534]
Pemetrexed DMMX2E6 Central nervous system lymphoma 2B33.5 Approved [534]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [173]
Selenium DM25CGV N. A. N. A. Approved [94]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [535]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [345]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [345]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [265]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [536]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [537]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bosutinib DMTI8YE Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [538]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [539]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
Quercetin DM3NC4M Obesity 5B81 Approved [540]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [541]
Plicamycin DM7C8YV Hypercalcaemia 5B91.0 Approved [542]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [543]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [543]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [355]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [62]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [544]
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [544]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [545]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [546]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [547]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [355]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [548]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [58]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Alpha-protein kinase 3 (ALPK3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [536]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [144]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [145]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [549]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [182]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [550]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [551]
Panobinostat DM58WKG Chronic graft versus host disease Approved [87]
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [549]
Testosterone DM7HUNW Hot flushes GA30 Approved [97]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [214]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [110]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [110]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [489]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [552]
Menthol DMG2KW7 Back pain ME84.Z Approved [323]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [410]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [553]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [554]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [159]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [291]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [65]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [555]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [556]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [162]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [557]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [558]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [559]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [560]
Gefitinib DM15F0X Colon adenocarcinoma Approved [561]
Prednisone DM2HG4X Acute asthma CA23 Approved [243]
Methotrexate DM2TEOL Anterior urethra cancer Approved [562]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [563]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [564]
Quercetin DM3NC4M Obesity 5B81 Approved [565]
Fluoxetine DM3PD2C Bipolar depression Approved [566]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [567]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [568]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Trastuzumab DMZQOUX Breast cancer 2C60-2C65 Approved [252]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [569]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [570]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [571]
Gefitinib DM15F0X Colon adenocarcinoma Approved [572]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [489]
Selenium DM25CGV N. A. N. A. Approved [94]
Methotrexate DM2TEOL Anterior urethra cancer Approved [288]
Quercetin DM3NC4M Obesity 5B81 Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [573]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [154]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [571]
Gefitinib DM15F0X Colon adenocarcinoma Approved [574]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [319]
Selenium DM25CGV N. A. N. A. Approved [575]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [576]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [122]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [577]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [133]
Testosterone enanthate DMB6871 N. A. N. A. Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [160]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [102]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [336]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [258]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [578]
Josamycin DMKJ8LB Bacterial infection 1A00-1C4Z Approved [579]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [578]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [111]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [63]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [580]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [336]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [581]
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [252]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [582]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [583]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [584]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [400]
Prednisone DM2HG4X Acute asthma CA23 Approved [585]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [586]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [587]
Methotrexate DM2TEOL Anterior urethra cancer Approved [90]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Olfactory receptor 4D6 (OR4D6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [143]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [147]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [94]
Quercetin DM3NC4M Obesity 5B81 Approved [84]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [338]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [324]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [588]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [589]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [590]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [94]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 2 (PARP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [591]
Methotrexate DM2TEOL Anterior urethra cancer Approved [72]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [132]
Testosterone DM7HUNW Hot flushes GA30 Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [112]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [310]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [137]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [119]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [336]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ribonucleoside-diphosphate reductase M2 (RRM2) TTBWDI0 RIR2_HUMAN Modulator [5]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
Concentrative nucleoside transporter 1 (SLC28A1) DT0EQPW S28A1_HUMAN Substrate [6]
Multidrug resistance-associated protein 5 (ABCC5) DTYVM24 MRP5_HUMAN Substrate [7]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [8]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytidine aminohydrolase (CDA) DEKEDRC CDD_HUMAN Substrate [9]
Cytidine deaminase (cdd) DETX3A5 CDD_ECOLI Substrate [10]
Cytidine deaminase (cdd) DEFVABT CDD_KLEP7 Substrate [10]
Uridine/cytidine monophosphate kinase (UMPK) DEMPH4I KCY_HUMAN Substrate [11]
Cytidine deaminase (cdd) DEYILK4 E0TLJ6_MYCHH Substrate [12]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1) OTG2T749 CP24A_HUMAN Gene/Protein Processing [13]
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (AGPAT2) OT5I4Y9K PLCB_HUMAN Gene/Protein Processing [13]
14-3-3 protein sigma (SFN) OTLJCZ1U 1433S_HUMAN Post-Translational Modifications [14]
3',5'-cyclic-AMP phosphodiesterase 4D (PDE4D) OT1RWFV0 PDE4D_HUMAN Drug Response [15]
5,6-dihydroxyindole-2-carboxylic acid oxidase OTRK49R4 TYRP1_HUMAN Gene/Protein Processing [13]
Alpha-2-macroglobulin (A2M) OTFTX90K A2MG_HUMAN Gene/Protein Processing [16]
Alpha-protein kinase 3 (ALPK3) OTLUYSMO ALPK3_HUMAN Drug Response [15]
Anaphase-promoting complex subunit 1 (ANAPC1) OT2YY35L APC1_HUMAN Gene/Protein Processing [13]
Ankyrin repeat domain-containing protein 1 (ANKRD1) OTHJ7JV9 ANKR1_HUMAN Gene/Protein Processing [13]
Ankyrin-3 (ANK3) OTJ3IRBP ANK3_HUMAN Gene/Protein Processing [13]

References

1 Gemcitabine FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4793).
4 Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93.
5 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
6 Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers (Basel). 2017 Nov 16;9(11).
7 Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia. 2010 Sep;12(9):740-7.
8 Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. Br J Cancer. 2003 Jun 16;88(12):1963-70.
9 Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. Br J Clin Pharmacol. 2011 Mar;71(3):437-44.
10 Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 Sep 15;357(6356):1156-1160.
11 Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics. Drug Metab Dispos. 2008 Sep;36(9):1951-9.
12 Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs. FEBS Open Bio. 2015 Aug 3;5:634-9.
13 Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007 Apr;102(2):157-72.
14 Reversible epigenetic regulation of 14-3-3 expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1. Mol Pharmacol. 2014 Nov;86(5):561-9. doi: 10.1124/mol.114.092544. Epub 2014 Sep 4.
15 Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. Cancer Sci. 2013 Aug;104(8):1074-82. doi: 10.1111/cas.12186. Epub 2013 Jun 10.
16 Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. Br J Cancer. 2010 Jun 29;103(1):52-60.
17 Cellular pharmacology of gemcitabine. Ann Oncol. 2006 May;17 Suppl 5:v7-12.
18 PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer's disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species. J Alzheimers Dis. 2009;17(3):611-9.
19 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
20 Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013 Jun;71(6):1645-55.
21 Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer Res. 2006 May-Jun;26(3A):1739-43.
22 Tezacitabine Hoechst Marion Roussel.Curr Opin Investig Drugs.2000 Sep;1(1):135-40.
23 Phase I and pharmacokinetic study of the oral tris-(8-quinolinolato)gallium(III) complex (FFC11, KP46) in patients with solid tumors - a study of the CESAR Central European Society for Anticancer Drug Research - EWIV. J Clin Oncol (Meeting Abstracts) June 2005 vol. 23 no. 16_suppl 3205.
24 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
25 MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemother Pharmacol. 2009 Jun;64(1):183-8.
26 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
27 Folate transporter expression decreases in the human placenta throughout pregnancy and in pre-eclampsia. Pregnancy Hypertens. 2012 Apr;2(2):123-31.
28 Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8.
29 Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92.
30 Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit. 2011 Apr;33(2):244-50.
31 The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res. 2005 May 15;65(10):4425-30.
32 ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology. 2009;9(1-2):136-44.
33 Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Curr Cancer Drug Targets. 2008 Aug;8(5):414-20.
34 Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine. Springerplus. 2014 Dec 13;3:732.
35 Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005;37(1):253-78.
36 Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem. 2007 Jul 20;282(29):20999-1004.
37 Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur J Pharm Sci. 2006 Apr;27(5):524-32.
38 Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci. 2002;4(3):E14.
39 The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem. 2000 Sep 29;275(39):30069-74.
40 FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia. Oncotarget. 2016 Aug 2;7(31):49786-49799.
41 Electrophysiological recordings of CNT1 (SLC28A1) activity on Nanions SURFE2R N1.
42 Lonsurf, INN-trifluridine/tipiracil.
43 Genetic factors influencing cytarabine therapy. Pharmacogenomics. 2009 Oct;10(10):1657-74.
44 Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. Int J Cancer. 2003 Sep 20;106(5):799-805.
45 A pilot pharmacokinetic study of oral azacitidine. Leukemia. 2008 Sep;22(9):1680-4.
46 Tracking decitabine incorporation into malignant myeloid cell DNA in vitro and in vivo by LC-MS/MS with enzymatic digestion. Sci Rep. 2019 Mar 14;9(1):4558.
47 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
48 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
49 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
50 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
51 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
52 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
53 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
54 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
55 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
56 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
57 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
58 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
59 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
60 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
61 E2F1 downregulation by arsenic trioxide in lung adenocarcinoma. Int J Oncol. 2014 Nov;45(5):2033-43. doi: 10.3892/ijo.2014.2609. Epub 2014 Aug 19.
62 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
63 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
64 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
65 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
66 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
67 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
68 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
69 Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics. 2008 Aug 7;9:376.
70 Death receptor 5 regulation during selenium-mediated apoptosis in human prostate cancer cells. Cancer Biol Ther. 2002 May-Jun;1(3):287-90. doi: 10.4161/cbt.83.
71 Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.
72 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
73 Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis. 2007 Oct;28(10):2114-21. doi: 10.1093/carcin/bgm133. Epub 2007 Jun 4.
74 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
75 Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010.
76 A genomic approach to predict synergistic combinations for breast cancer treatment. Pharmacogenomics J. 2013 Feb;13(1):94-104. doi: 10.1038/tpj.2011.48. Epub 2011 Nov 15.
77 Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma. Oncogene. 2005 Jan 13;24(3):419-30. doi: 10.1038/sj.onc.1208212.
78 Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors. Toxicol In Vitro. 2015 Sep;29(6):1231-9. doi: 10.1016/j.tiv.2014.10.012. Epub 2014 Oct 24.
79 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
80 [Effect of nylestriol and levonorgestrel on the expression of Opg/OPGL in human osteosarcoma MG-63 cell lines]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Dec;29(6):667-70.
81 Chronic senescent human mesenchymal stem cells as possible contributor to the wound healing disorder after exposure to the alkylating agent sulfur mustard. Arch Toxicol. 2021 Feb;95(2):727-747. doi: 10.1007/s00204-020-02946-5. Epub 2021 Jan 25.
82 Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Arthritis Rheum. 2004 Dec;50(12):3831-43. doi: 10.1002/art.20637.
83 [Effect of simvastatin on the function of MG63 cell line]. Shanghai Kou Qiang Yi Xue. 2010 Dec;19(6):658-62.
84 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
85 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
86 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
87 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
88 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664. doi: 10.1016/j.fct.2021.112664. Epub 2021 Nov 9.
89 Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett. 2006 Mar 13;395(3):185-90. doi: 10.1016/j.neulet.2005.10.096. Epub 2005 Dec 1.
90 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
91 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
92 Effects of four-week high-fructose diet on gene expression in skeletal muscle of healthy men. Diabetes Metab. 2008 Feb;34(1):82-5. doi: 10.1016/j.diabet.2007.08.004. Epub 2007 Dec 11.
93 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
94 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
95 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
96 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
97 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
98 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
99 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
100 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
101 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
102 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
103 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
104 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
105 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
106 Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
107 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
108 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
109 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
110 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
111 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
112 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
113 Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells. Neoplasia. 2006 Sep;8(9):758-71.
114 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
115 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
116 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
117 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
118 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
119 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
120 Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma. 2007 Aug;48(8):1610-7. doi: 10.1080/10428190701471999.
121 Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031-8. doi: 10.1158/1535-7163.MCT-06-0643. Epub 2007 Mar 5.
122 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
123 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
124 An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089257. doi: 10.1177/09603271221089257.
125 Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.
126 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
127 Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis. 2010 Feb;15(2):219-29. doi: 10.1007/s10495-009-0424-9.
128 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
129 Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci. 2013 Aug;134(2):323-34. doi: 10.1093/toxsci/kft105. Epub 2013 May 2.
130 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
131 Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene. 2005 Feb 3;24(6):980-91. doi: 10.1038/sj.onc.1208095.
132 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
133 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
134 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
135 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
136 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
137 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
138 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
139 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
140 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
141 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
142 Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs). Toxicol In Vitro. 2010 Sep;24(6):1696-704. doi: 10.1016/j.tiv.2010.05.017. Epub 2010 May 26.
143 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
144 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
145 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
146 Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-beta-dependent mechanisms. Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4558-66.
147 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
148 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
149 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
150 Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays. Cancer Res. 2006 Dec 15;66(24):12009-18.
151 A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 2006 Dec;3(12):e486. doi: 10.1371/journal.pmed.0030486.
152 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
153 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
154 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
155 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
156 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
157 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
158 Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis. 2010 Jun 2;9:56. doi: 10.1186/1476-511X-9-56.
159 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
160 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
161 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
162 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
163 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
164 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
165 Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Oncotarget. 2017 Jul 4;8(27):43678-43691. doi: 10.18632/oncotarget.18435.
166 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
167 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
168 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
169 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
170 The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr J. 2005 Mar 4;4:11.
171 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
172 Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci. 2011 Mar;120(1):109-22.
173 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
174 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
175 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
176 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
177 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
178 Zinc induces chemokine and inflammatory cytokine release from human promonocytes. J Hazard Mater. 2011 Nov 30;196:335-41. doi: 10.1016/j.jhazmat.2011.09.035. Epub 2011 Sep 19.
179 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
180 Evaluation of early biomarkers of muscle anabolic response to testosterone. J Cachexia Sarcopenia Muscle. 2011 Mar;2(1):45-56. doi: 10.1007/s13539-011-0021-y. Epub 2011 Feb 26.
181 Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002 Jun;16(6):1243-56.
182 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
183 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
184 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther. 2003 Jun;305(3):932-42. doi: 10.1124/jpet.103.049098. Epub 2003 Mar 20.
185 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
186 Hypomethylation mediated by decreased DNMTs involves in the activation of proto-oncogene MPL in TK6 cells treated with hydroquinone. Toxicol Lett. 2012 Mar 25;209(3):239-45. doi: 10.1016/j.toxlet.2011.12.020. Epub 2012 Jan 8.
187 Thalidomide alters c-MYB and PIM-1 signaling in K-562 cells. Pharmacol Res. 2006 Aug;54(2):91-6. doi: 10.1016/j.phrs.2006.02.010. Epub 2006 Mar 8.
188 Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):701-6. doi: 10.1042/bj2900701.
189 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
190 A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
191 In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci. 2007 Sep;99(1):162-73.
192 Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta. 2005 Oct 15;1731(1):48-56. doi: 10.1016/j.bbaexp.2005.08.006. Epub 2005 Sep 1.
193 Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2.
194 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
195 Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
196 Nitric oxide causes anoikis through attenuation of E-cadherin and activation of caspase-3 in human gastric carcinoma AZ-521 cells infected with Mycoplasma hyorhinis. J Vet Med Sci. 2010 Jul;72(7):869-74.
197 Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci. 1999 Aug;112 ( Pt 16):2657-66. doi: 10.1242/jcs.112.16.2657.
198 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
199 Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9. doi: 10.1016/j.bbrc.2009.01.134. Epub 2009 Jan 27.
200 Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One. 2012;7(4):e36110.
201 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
202 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
203 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
204 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
205 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
206 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
207 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
208 Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2014 Mar;35(3):692-702. doi: 10.1093/carcin/bgt366. Epub 2013 Nov 5.
209 Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg. 2004 Oct;101(4):659-63. doi: 10.3171/jns.2004.101.4.0659.
210 Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma. Med Hypotheses. 2005;65(4):819-20. doi: 10.1016/j.mehy.2005.04.007.
211 Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. Int J Cancer. 2003 Feb 20;103(5):686-92. doi: 10.1002/ijc.10849.
212 Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells. Mol Pharmacol. 2008 Aug;74(2):517-26. doi: 10.1124/mol.107.043620. Epub 2008 May 20.
213 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
214 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
215 Considering temozolomide as a novel potential treatment for esophageal cancer. Cancer. 2011 May 1;117(9):2004-16. doi: 10.1002/cncr.25687. Epub 2010 Nov 8.
216 Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicol Sci. 2011 Dec;124(2):278-90. doi: 10.1093/toxsci/kfr225. Epub 2011 Aug 27.
217 Mapping the dynamics of Nrf2 antioxidant and NFB inflammatory responses by soft electrophilic chemicals in human liver cells defines the transition from adaptive to adverse responses. Toxicol In Vitro. 2022 Oct;84:105419. doi: 10.1016/j.tiv.2022.105419. Epub 2022 Jun 17.
218 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
219 The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro. Toxicol Appl Pharmacol. 2020 Mar 15;391:114915. doi: 10.1016/j.taap.2020.114915. Epub 2020 Feb 6.
220 Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem. 2003 Nov 28;278(48):47762-75.
221 Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J. 2006 Feb 15;394(Pt 1):317-24.
222 Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2006 Mar;79(3):529-38. doi: 10.1189/jlb.0205064. Epub 2005 Dec 30.
223 Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep. 2016 Sep;36(3):1233-42. doi: 10.3892/or.2016.4944. Epub 2016 Jul 15.
224 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000 Mar 1;164(5):2405-11. doi: 10.4049/jimmunol.164.5.2405.
225 Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis. Leukemia. 2010 Aug;24(8):1476-86. doi: 10.1038/leu.2010.117. Epub 2010 Jun 3.
226 Bisphenol A effects on gene expression in adipocytes from children: association with metabolic disorders. J Mol Endocrinol. 2015 Jun;54(3):289-303.
227 Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men. Biol Reprod. 2009 Mar;80(3):484-92.
228 Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respir Res. 2005 Aug 8;6(1):89. doi: 10.1186/1465-9921-6-89.
229 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
230 Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet Genomics. 2006 Apr;16(4):287-96. doi: 10.1097/01.fpc.0000189800.88596.7a.
231 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
232 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
233 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
234 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
235 Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo. Toxicol Appl Pharmacol. 2014 Jan 15;274(2):302-12.
236 Mitochondrial dysfunction induced by leflunomide and its active metabolite. Toxicology. 2018 Mar 1;396-397:33-45.
237 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
238 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
239 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
240 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
241 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
242 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
243 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
244 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
245 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
246 Gene expression profile changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin. 2003 Jul;24(7):646-50.
247 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
248 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
249 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
250 Tyrosine phosphorylation of the scaffold protein IQGAP1 in the MET pathway alters function. J Biol Chem. 2020 Dec 25;295(52):18105-18121. doi: 10.1074/jbc.RA120.015891. Epub 2020 Oct 21.
251 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
252 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
253 Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2002 May;122(5):339-61.
254 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
255 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
256 Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
257 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
258 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
259 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
260 Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. Chem Biol Interact. 2017 Sep 25;275:22-34. doi: 10.1016/j.cbi.2017.07.023. Epub 2017 Jul 27.
261 Transcription Factor IIA tau is associated with undifferentiated cells and its gene expression is repressed in primary neurons at the chromatin level in vivo. Stem Cells Dev. 2006 Apr;15(2):175-90. doi: 10.1089/scd.2006.15.175.
262 Arsenic-induced sumoylation of Mus81 is involved in regulating genomic stability. Cell Cycle. 2017 Apr 18;16(8):802-811. doi: 10.1080/15384101.2017.1302628. Epub 2017 Mar 20.
263 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
264 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
265 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
266 Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril. 2008 Dec;90(6):2152-64.
267 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
268 Astaxanthin protects mesenchymal stem cells from oxidative stress by direct scavenging of free radicals and modulation of cell signaling. Chem Biol Interact. 2021 Jan 5;333:109324. doi: 10.1016/j.cbi.2020.109324. Epub 2020 Nov 17.
269 Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr. 2012 Mar;107(6):781-90. doi: 10.1017/S0007114511003631. Epub 2011 Aug 1.
270 Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. Int J Mol Sci. 2023 Mar 15;24(6):5604. doi: 10.3390/ijms24065604.
271 Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway. Cancer Cell Int. 2013 Mar 13;13(1):25. doi: 10.1186/1475-2867-13-25.
272 Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Chin Med J (Engl). 2009 Jun 5;122(11):1260-6.
273 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
274 Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer. 2006 May 18;5:20. doi: 10.1186/1476-4598-5-20.
275 RAB8 enhances TMEM205-mediated cisplatin resistance. Pharm Res. 2012 Mar;29(3):643-50. doi: 10.1007/s11095-011-0562-y. Epub 2011 Oct 4.
276 TGF-1 signaling protects retinal ganglion cells from oxidative stress via modulation of the HO-1/Nrf2 pathway. Chem Biol Interact. 2020 Nov 1;331:109249. doi: 10.1016/j.cbi.2020.109249. Epub 2020 Sep 24.
277 Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells. Mol Vis. 2008 Jan 18;14:95-104.
278 Towards dissecting the pathogenesis of retinoid-induced hair loss: all-trans retinoic acid induces premature hair follicle regression (catagen) by upregulation of transforming growth factor-beta2 in the dermal papilla. J Invest Dermatol. 2005 Jun;124(6):1119-26. doi: 10.1111/j.0022-202X.2005.23686.x.
279 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
280 Role of microRNA-4516 involved autophagy associated with exposure to fine particulate matter. Oncotarget. 2016 Jul 19;7(29):45385-45397. doi: 10.18632/oncotarget.9978.
281 Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer. 2006 Sep 1;119(5):1164-75.
282 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
283 Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol. 2012 Jul;41(1):369-77.
284 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
285 A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):904-12. doi: 10.1016/j.ijrobp.2008.10.032.
286 Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009 Dec 24;114(27):5512-21. doi: 10.1182/blood-2009-02-204834. Epub 2009 Oct 14.
287 Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clin Exp Immunol. 2012 Apr;168(1):113-24. doi: 10.1111/j.1365-2249.2011.04549.x.
288 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
289 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
290 MiR-146a affects the alteration in myeloid differentiation induced by hydroquinone in human CD34(+) hematopoietic progenitor cells and HL-60 cells. Toxicol Res (Camb). 2016 Feb 16;5(3):848-858. doi: 10.1039/c5tx00419e. eCollection 2016 May 1.
291 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
292 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
293 Linalool is a PPARalpha ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome. J Lipid Res. 2014 Jun;55(6):1098-110.
294 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
295 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.
296 ATPR induces acute promyelocytic leukemia cells differentiation and growth arrest by blockade of SHP2/Rho/ROCK1 pathway. Toxicol Appl Pharmacol. 2020 Jul 15;399:115053. doi: 10.1016/j.taap.2020.115053. Epub 2020 May 15.
297 Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. Med Oncol. 2010 Sep;27(3):833-42. doi: 10.1007/s12032-009-9294-9. Epub 2009 Sep 10.
298 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
299 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
300 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
301 Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells. J Biol Chem. 2018 Jul 13;293(28):11076-11087. doi: 10.1074/jbc.RA117.001244. Epub 2018 May 24.
302 DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. Physiol Genomics. 2004 Apr 13;17(2):122-9. doi: 10.1152/physiolgenomics.00002.2003.
303 Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells. Biochem Biophys Res Commun. 2005 Dec 30;338(4):1973-81. doi: 10.1016/j.bbrc.2005.10.178. Epub 2005 Nov 7.
304 Actions of Vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Endocrinology. 1995 Jan;136(1):20-6.
305 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
306 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
307 Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest. 2005 Jan;115(1):177-86.
308 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer Res. 2005 Mar 15;65(6):2488-97.
309 Similarities and differences between two modes of antagonism of the thyroid hormone receptor. ACS Chem Biol. 2011 Oct 21;6(10):1096-106.
310 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
311 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
312 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
313 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
314 Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. Sci Rep. 2019 Jan 24;9(1):675.
315 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
316 High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities. Arch Toxicol. 2017 Mar;91(3):1367-1383. doi: 10.1007/s00204-016-1781-0. Epub 2016 Jun 29.
317 Association of H3K79 monomethylation (an epigenetic signature) with arsenic-induced skin lesions. Mutat Res. 2018 Jan;807:1-9. doi: 10.1016/j.mrfmmm.2017.11.001. Epub 2017 Nov 14.
318 Effects of Benzophenone-3 and Propylparaben on Estrogen Receptor-Dependent R-Loops and DNA Damage in Breast Epithelial Cells and Mice. Environ Health Perspect. 2020 Jan;128(1):17002. doi: 10.1289/EHP5221. Epub 2020 Jan 15.
319 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
320 Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse. Int J Cancer. 2008 Apr 1;122(7):1645-56. doi: 10.1002/ijc.23280.
321 2,3,7,8-tetrachlorodibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptor. Toxicol Appl Pharmacol. 2004 Feb 1;194(3):201-10. doi: 10.1016/j.taap.2003.09.010.
322 Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis. 2006 May;27(5):916-24. doi: 10.1093/carcin/bgi312. Epub 2005 Dec 16.
323 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
324 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
325 Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther. 2004 Jan;3(1):71-84.
326 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
327 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
328 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
329 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.
330 Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res. 2005 Sep 1;65(17):7856-65. doi: 10.1158/0008-5472.CAN-05-1056.
331 The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells. Chem Biol Interact. 2019 Apr 1;302:28-35. doi: 10.1016/j.cbi.2019.01.033. Epub 2019 Jan 28.
332 Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO). Int J Biochem Cell Biol. 2019 Nov;116:105615. doi: 10.1016/j.biocel.2019.105615. Epub 2019 Sep 17.
333 Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells. Eur J Haematol. 2005 Sep;75(3):212-20. doi: 10.1111/j.1600-0609.2005.00498.x.
334 Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther. 2002 Jul;1(9):667-77.
335 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
336 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
337 Molecular characterization of a toxicological tipping point during human stem cell differentiation. Reprod Toxicol. 2020 Jan;91:1-13. doi: 10.1016/j.reprotox.2019.10.001. Epub 2019 Oct 7.
338 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
339 5-Fluorouracil: identification of novel downstream mediators of tumour response. Anticancer Res. 2004 Mar-Apr;24(2A):417-23.
340 Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
341 High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells. Br J Nutr. 2008 Apr;99(4):703-8.
342 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
343 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
344 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
345 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
346 Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. Cancer Genet Cytogenet. 2006 Apr 15;166(2):130-8. doi: 10.1016/j.cancergencyto.2005.09.012.
347 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
348 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
349 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
350 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
351 Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007 Nov;3(11):e207.
352 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
353 Transcriptome dynamics of alternative splicing events revealed early phase of apoptosis induced by methylparaben in H1299 human lung carcinoma cells. Arch Toxicol. 2020 Jan;94(1):127-140. doi: 10.1007/s00204-019-02629-w. Epub 2019 Nov 20.
354 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
355 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
356 Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med. 2010 Apr 12;207(4):731-50. doi: 10.1084/jem.20091488. Epub 2010 Apr 5.
357 ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer. 2006 Jan 15;118(2):483-9. doi: 10.1002/ijc.21340.
358 Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells. J Steroid Biochem Mol Biol. 2003 May;85(1):1-8. doi: 10.1016/s0960-0760(03)00142-0.
359 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
360 In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells. Arch Toxicol. 2016 Mar;90(3):677-89. doi: 10.1007/s00204-015-1483-z. Epub 2015 Feb 26.
361 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
362 Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells. World J Gastroenterol. 2005 Oct 7;11(37):5763-9. doi: 10.3748/wjg.v11.i37.5763.
363 Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics. 2003 Jun;81(6):543-55.
364 Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol. 2016 Jul;90(7):1685-94. doi: 10.1007/s00204-015-1585-7. Epub 2015 Aug 28.
365 A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system. Toxicol Lett. 2014 Nov 18;231(1):38-44.
366 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
367 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
368 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
369 Capsaicin inhibits the migration, invasion and EMT of renal cancer cells by inducing AMPK/mTOR-mediated autophagy. Chem Biol Interact. 2022 Oct 1;366:110043. doi: 10.1016/j.cbi.2022.110043. Epub 2022 Aug 28.
370 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
371 Identification of troglitazone responsive genes: induction of RTP801 during troglitazone-induced apoptosis in Hep 3B cells. BMB Rep. 2010 Sep;43(9):599-603. doi: 10.5483/BMBRep.2010.43.9.599.
372 In vitro effects of aldehydes present in tobacco smoke on gene expression in human lung alveolar epithelial cells. Toxicol In Vitro. 2013 Apr;27(3):1072-81.
373 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
374 Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol. 2012 Dec 10;6:152.
375 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
376 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
377 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
378 An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp Hematol. 2007 Feb;35(2):252-62.
379 Selenium is critical for cancer-signaling gene expression but not cell proliferation in human colon Caco-2 cells. Biofactors. 2007;31(3-4):155-64. doi: 10.1002/biof.5520310302.
380 Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report. Am J Ther. 2001 Mar-Apr;8(2):97-107. doi: 10.1097/00045391-200103000-00004.
381 Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull. 2007 Feb;30(2):247-53. doi: 10.1248/bpb.30.247.
382 Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002 Nov;46(11):3034-40. doi: 10.1002/art.10617.
383 Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004 Oct;50(10):3286-95. doi: 10.1002/art.20518.
384 Quercetin inhibits IL-1-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation. 2012 Aug;35(4):1585-94. doi: 10.1007/s10753-012-9473-2.
385 Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin Pharmacol Ther. 2006 Apr;79(4):303-15. doi: 10.1016/j.clpt.2005.12.306.
386 Monomeric and oligomeric flavanols maintain the endogenous glucocorticoid response in human macrophages in pro-oxidant conditions in vitro. Chem Biol Interact. 2018 Aug 1;291:237-244.
387 Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1 or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling. Arch Oral Biol. 2012 May;57(5):483-90. doi: 10.1016/j.archoralbio.2011.10.007. Epub 2011 Nov 25.
388 Ca(2+) Signaling and IL-8 Secretion in Human Testicular Peritubular Cells Involve the Cation Channel TRPV2. Int J Mol Sci. 2018 Sep 19;19(9):2829. doi: 10.3390/ijms19092829.
389 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
390 Nitrogen mustard prevents transport of Fra-1 into the nucleus to promote c-Fos- and FosB-dependent IL-8 induction in injured mouse epidermis. Toxicol Lett. 2020 Feb 1;319:256-263. doi: 10.1016/j.toxlet.2019.10.006. Epub 2019 Oct 19.
391 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
392 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
393 Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am J Respir Crit Care Med. 2000 Jan;161(1):249-56. doi: 10.1164/ajrccm.161.1.9804096.
394 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
395 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
396 Identification of human cell responses to benzene and benzene metabolites. Genomics. 2007 Sep;90(3):324-33.
397 Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. Leuk Res. 2010 Jul;34(7):917-24. doi: 10.1016/j.leukres.2009.12.002. Epub 2010 Feb 8.
398 Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicol Lett. 2021 Mar 1;338:1-9. doi: 10.1016/j.toxlet.2020.11.011. Epub 2020 Nov 25.
399 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
400 Cannabidiol selectively modulates interleukin (IL)-1 and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021 Dec;464:153016. doi: 10.1016/j.tox.2021.153016. Epub 2021 Nov 2.
401 Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. J Biol Chem. 2016 Feb 12;291(7):3639-47. doi: 10.1074/jbc.M115.679704. Epub 2015 Dec 18.
402 Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1194-9. doi: 10.1161/01.atv.0000022694.16328.cc.
403 Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011 Sep 1;255(2):138-49.
404 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
405 How benzene and its metabolites affect human marrow derived mesenchymal stem cells. Toxicol Lett. 2012 Oct 17;214(2):145-53. doi: 10.1016/j.toxlet.2012.08.015. Epub 2012 Aug 30.
406 Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002.
407 Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study. Am Heart J. 2006 Jan;151(1):139. doi: 10.1016/j.ahj.2005.10.006.
408 Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Eur J Pharmacol. 2004 Sep 24;499(3):315-24. doi: 10.1016/j.ejphar.2004.07.114.
409 Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. Diabetes Care. 2006 Feb;29(2):195-201. doi: 10.2337/diacare.29.02.06.dc05-1418.
410 Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 2009 Mar;144(5):667-76. doi: 10.1111/j.1365-2141.2008.07504.x. Epub 2008 Nov 20.
411 Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial. J Invasive Cardiol. 2006 Jan;18(1):6-12.
412 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
413 Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):281-9.
414 Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J Pharmacol Exp Ther. 2002 Oct;303(1):300-7. doi: 10.1124/jpet.102.036939.
415 Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC). Front Microbiol. 2015 Dec 22;6:1452. doi: 10.3389/fmicb.2015.01452. eCollection 2015.
416 The THP-1 cell toolbox: a new concept integrating the key events of skin sensitization. Arch Toxicol. 2019 Apr;93(4):941-951.
417 Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women. Arch Toxicol. 2017 May;91(5):2067-2078. doi: 10.1007/s00204-016-1879-4. Epub 2016 Nov 12.
418 Quercetin attenuates cell apoptosis of oxidant-stressed SK-N-MC cells while suppressing up-regulation of the defensive element, HIF-1alpha. Neuroscience. 2014 Sep 26;277:780-93.
419 Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. Int J Mol Sci. 2012;13(8):9627-9641. doi: 10.3390/ijms13089627. Epub 2012 Aug 2.
420 Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway. Chem Biol Interact. 2018 Oct 1;294:28-33. doi: 10.1016/j.cbi.2018.08.018. Epub 2018 Aug 18.
421 NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. J Biol Chem. 2019 May 24;294(21):8543-8554. doi: 10.1074/jbc.RA118.006983. Epub 2019 Apr 2.
422 The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J Cell Biochem. 2009 Mar 1;106(4):682-92. doi: 10.1002/jcb.22065.
423 Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells. Toxicol Appl Pharmacol. 2020 Jun 1;396:115001. doi: 10.1016/j.taap.2020.115001. Epub 2020 Apr 8.
424 mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. Cancer Sci. 2008 Oct;99(10):1992-2003. doi: 10.1111/j.1349-7006.2008.00955.x.
425 Assessment of the cytotoxic, genotoxic, and apoptotic potential of flurbiprofen in HeLa and HepG2 cell lines. J Biochem Mol Toxicol. 2021 Jun;35(6):1-11. doi: 10.1002/jbt.22770. Epub 2021 Mar 11.
426 Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin. Invest New Drugs. 2011 Oct;29(5):945-52. doi: 10.1007/s10637-010-9450-2. Epub 2010 May 13.
427 Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells. Oncogene. 2005 Sep 15;24(41):6213-21. doi: 10.1038/sj.onc.1208774.
428 Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest. 2009 Jul;27(6):604-12. doi: 10.1080/07357900802337191.
429 Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. Apoptosis. 2006 Sep;11(9):1503-12. doi: 10.1007/s10495-006-8896-3.
430 Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. Toxicol Sci. 2007 Mar;96(1):101-14.
431 Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell. J Dent. 2021 Jun;109:103673. doi: 10.1016/j.jdent.2021.103673. Epub 2021 Apr 16.
432 Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture. Toxicology. 2009 Mar 4;257(1-2):10-6. doi: 10.1016/j.tox.2008.12.002. Epub 2008 Dec 9.
433 Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines. Toxicol Appl Pharmacol. 2014 Nov 1;280(3):550-60.
434 Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G533-49. doi: 10.1152/ajpgi.00428.2013. Epub 2014 Jul 17.
435 The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am. 2001 Feb;83(2):201-11. doi: 10.2106/00004623-200102000-00007.
436 Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum. 2006 Apr;54(4):1298-308. doi: 10.1002/art.21723.
437 Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy. Invest Ophthalmol Vis Sci. 2012 Aug 31;53(9):5921-9. doi: 10.1167/iovs.12-9646.
438 Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412-22. doi: 10.1016/j.cbi.2013.03.011. Epub 2013 Mar 22.
439 Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. J Investig Med. 2001 Jan;49(1):68-76. doi: 10.2310/6650.2001.34092.
440 The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338-47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7.
441 Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73:105138. doi: 10.1016/j.tiv.2021.105138. Epub 2021 Mar 6.
442 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
443 Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288-95. doi: 10.1111/j.1365-2249.2007.03335.x. Epub 2007 Feb 7.
444 Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-/Smad signaling pathways. Cell Biol Toxicol. 2021 Jun;37(3):479-496. doi: 10.1007/s10565-020-09562-0. Epub 2020 Oct 17.
445 Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One. 2011;6(11):e27306. doi: 10.1371/journal.pone.0027306. Epub 2011 Nov 8.
446 Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. PLoS One. 2013 Jul 8;8(7):e69466. doi: 10.1371/journal.pone.0069466. Print 2013.
447 DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009 May 14;28(19):2046-50. doi: 10.1038/onc.2009.62. Epub 2009 Apr 13.
448 Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect. J Zhejiang Univ Sci B. 2008 Jan;9(1):22-33. doi: 10.1631/jzus.B071322.
449 Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism. Chem Biol Interact. 2016 Apr 25;250:1-11.
450 Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. J Biol Chem. 2011 Apr 1;286(13):11314-27. doi: 10.1074/jbc.M110.193714. Epub 2011 Jan 3.
451 Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. Curr Pharm Des. 2013;19(5):940-50.
452 Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. Oncotarget. 2016 Nov 22;7(47):77543-77557. doi: 10.18632/oncotarget.12721.
453 Hsa-let-7g miRNA regulates the anti-tumor effects of gastric cancer cells under oxidative stress through the expression of DDR genes. J Toxicol Sci. 2015 Jun;40(3):329-38. doi: 10.2131/jts.40.329.
454 Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology. 2020 Apr 15;435:152422. doi: 10.1016/j.tox.2020.152422. Epub 2020 Feb 26.
455 Synthesis and structure-activity relationships of new antiproliferative and proapoptotic retinoid-related biphenyl-4-yl-acrylic acids. Bioorg Med Chem. 2007 Jul 15;15(14):4863-75. doi: 10.1016/j.bmc.2007.04.057. Epub 2007 May 3.
456 Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol. 2011 Feb 15;81(4):510-7. doi: 10.1016/j.bcp.2010.11.014. Epub 2010 Nov 27.
457 Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133(+) HCC. Chem Biol Interact. 2019 Aug 25;309:108713. doi: 10.1016/j.cbi.2019.06.026. Epub 2019 Jun 19.
458 Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. Ann Hematol. 2010 Nov;89(11):1115-24. doi: 10.1007/s00277-010-0988-z. Epub 2010 May 25.
459 The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicol Sci. 2023 Dec 21;197(1):69-78. doi: 10.1093/toxsci/kfad099.
460 The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. DNA Repair (Amst). 2004 Mar 4;3(3):235-44. doi: 10.1016/j.dnarep.2003.10.014.
461 Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem. 2006 Dec;387(12):1629-33. doi: 10.1515/BC.2006.203.
462 Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 2000 Feb;45(3):788-94. doi: 10.1016/s0008-6363(99)00369-7.
463 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
464 Regulatory role of KEAP1 and NRF2 in PPAR expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic Biol Med. 2012 Aug 15;53(4):758-68. doi: 10.1016/j.freeradbiomed.2012.05.041. Epub 2012 Jun 7.
465 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
466 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
467 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
468 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
469 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
470 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
471 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
472 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
473 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
474 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
475 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
476 Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol. 2006 Nov;70(5):1664-71. doi: 10.1124/mol.106.025817. Epub 2006 Jul 31.
477 Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol In Vitro. 2011 Apr;25(3):671-83.
478 Omeprazole inhibits pancreatic cancer cell invasion through a nongenomic aryl hydrocarbon receptor pathway. Chem Res Toxicol. 2015 May 18;28(5):907-18.
479 Ligand-independent activation of AhR by hydroquinone mediates benzene-induced hematopoietic toxicity. Chem Biol Interact. 2022 Mar 1;355:109845. doi: 10.1016/j.cbi.2022.109845. Epub 2022 Feb 4.
480 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
481 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
482 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
483 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
484 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
485 Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 2008 Jun;46(6):2042-53. doi: 10.1016/j.fct.2008.01.049. Epub 2008 Feb 7.
486 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
487 Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenase. J Biol Chem. 2013 Oct 4;288(40):28792-800. doi: 10.1074/jbc.M113.491365. Epub 2013 Aug 12.
488 Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020 Feb 14;10(1):2687. doi: 10.1038/s41598-020-59468-4.
489 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
490 Sulindac suppresses beta-catenin expression in human cancer cells. Eur J Pharmacol. 2008 Mar 31;583(1):26-31. doi: 10.1016/j.ejphar.2007.12.034. Epub 2008 Feb 5.
491 Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation. Mol Cell Endocrinol. 2012 Jan 2;348(1):260-9. doi: 10.1016/j.mce.2011.09.002. Epub 2011 Sep 6.
492 Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib. Leuk Res. 2008 Nov;32(11):1674-83. doi: 10.1016/j.leukres.2008.03.039. Epub 2008 May 15.
493 Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A. Oncogene. 2006 Oct 19;25(49):6447-56. doi: 10.1038/sj.onc.1209658. Epub 2006 Jul 31.
494 Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of -catenin signaling. Toxicol In Vitro. 2018 Feb;46:361-369. doi: 10.1016/j.tiv.2017.08.018. Epub 2017 Sep 5.
495 Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways. Toxicol In Vitro. 2017 Apr;40:324-335. doi: 10.1016/j.tiv.2017.01.019. Epub 2017 Feb 2.
496 Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia. Clin Cancer Res. 2017 Feb 1;23(3):789-803. doi: 10.1158/1078-0432.CCR-16-0226. Epub 2016 Aug 4.
497 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
498 Pro-oxidant induced DNA damage in human lymphoblastoid cells: homeostatic mechanisms of genotoxic tolerance. Toxicol Sci. 2012 Aug;128(2):387-97. doi: 10.1093/toxsci/kfs152. Epub 2012 Apr 26.
499 Differential gene expression of sulindac-treated human breast epithelial cells. Int J Oncol. 2005 Dec;27(6):1727-36.
500 Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling pathways and endoplasmic reticulum stress in furazolidone induced cytotoxicity and S phase arrest in human hepatocyte L02 cells: modulation of curcumin. Toxicol Mech Methods. 2017 Mar;27(3):165-172. doi: 10.1080/15376516.2016.1273424. Epub 2017 Jan 8.
501 Sevoflurane-mediated activation of p38-mitogen-activated stresskinase is independent of apoptosis in Jurkat T-cells. Anesth Analg. 2008 Apr;106(4):1150-60, table of contents. doi: 10.1213/ane.0b013e3181683d37.
502 Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009 Feb 27;256(3):183-90. doi: 10.1016/j.tox.2008.11.016. Epub 2008 Nov 28.
503 PLK1 targets NOTCH1 during DNA damage and mitotic progression. J Biol Chem. 2019 Nov 22;294(47):17941-17950. doi: 10.1074/jbc.RA119.009881. Epub 2019 Oct 9.
504 Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells. Cell Biol Int. 2011 Aug;35(8):803-10. doi: 10.1042/CBI20100739.
505 Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G731-8. doi: 10.1152/ajpgi.00150.2005. Epub 2005 Jun 23.
506 p38 MAPK/PP2Ac/TTP pathway on the connection of TNF- and caspases activation on hydroquinone-induced apoptosis. Carcinogenesis. 2013 Apr;34(4):818-27. doi: 10.1093/carcin/bgs409. Epub 2013 Jan 3.
507 Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer. Head Neck. 2013 Mar;35(3):413-9. doi: 10.1002/hed.22982. Epub 2012 Mar 16.
508 Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021 Feb;11(2):e335. doi: 10.1002/ctm2.335.
509 Altered expression of genes identified in rats with prostatic chronic inflammation in a prostate spheroid model treated by estradiol/testosterone. J Toxicol Sci. 2021;46(11):515-523. doi: 10.2131/jts.46.515.
510 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
511 Effects of Exposure to Acetaminophen and Ibuprofen on Fetal Germ Cell Development in Both Sexes in Rodent and Human Using Multiple Experimental Systems. Environ Health Perspect. 2018 Apr 16;126(4):047006. doi: 10.1289/EHP2307.
512 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
513 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
514 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
515 Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology. 2007 May;121(1):71-81. doi: 10.1111/j.1365-2567.2006.02539.x.
516 Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol. 2010 Jun 10;635(1-3):219-26. doi: 10.1016/j.ejphar.2010.02.044. Epub 2010 Mar 20.
517 Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol. 2005 May;67(5):1808-17. doi: 10.1124/mol.104.005769. Epub 2005 Feb 9.
518 Role of BAX in the apoptotic response to anticancer agents. Science. 2000 Nov 3;290(5493):989-92. doi: 10.1126/science.290.5493.989.
519 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290.
520 Chronic ethanol exposure increases goosecoid (GSC) expression in human embryonic carcinoma cell differentiation. J Appl Toxicol. 2014 Jan;34(1):66-75.
521 PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. Br J Cancer. 2008 Oct 21;99(8):1276-84. doi: 10.1038/sj.bjc.6604665.
522 Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput reporter and endogenous gene responses. Toxicol In Vitro. 2015 Oct;29(7):1609-18. doi: 10.1016/j.tiv.2015.06.018. Epub 2015 Jun 19.
523 White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol. 2015 Jan;17(1):57-67. doi: 10.1038/ncb3075. Epub 2014 Dec 8.
524 Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells. Acta Biochim Biophys Sin (Shanghai). 2008 Sep;40(9):819-29.
525 Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014 Jul;46(7):722-5. doi: 10.1038/ng.2986. Epub 2014 May 25.
526 Methylparaben stimulates tumor initiating cells in ER+ breast cancer models. J Appl Toxicol. 2017 Apr;37(4):417-425. doi: 10.1002/jat.3374. Epub 2016 Sep 1.
527 Ivermectin as an inhibitor of cancer stem?like cells. Mol Med Rep. 2018 Feb;17(2):3397-3403. doi: 10.3892/mmr.2017.8231. Epub 2017 Dec 8.
528 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
529 Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug;11(8):1703-12.
530 Estrogen receptor alpha (ER)-mediated coregulator binding and gene expression discriminates the toxic ER agonist diethylstilbestrol (DES) from the endogenous ER agonist 17-estradiol (E2). Cell Biol Toxicol. 2020 Oct;36(5):417-435. doi: 10.1007/s10565-020-09516-6. Epub 2020 Feb 22.
531 Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor alpha signalling and results in tamoxifen insensitive proliferation. BMC Cancer. 2014 Apr 23;14:283.
532 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
533 Nuclear proteome analysis of cisplatin-treated HeLa cells. Mutat Res. 2010 Sep 10;691(1-2):1-8. doi: 10.1016/j.mrfmmm.2010.06.002. Epub 2010 Jun 9.
534 Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators. Cancer Res. 2005 Aug 1;65(15):6593-600. doi: 10.1158/0008-5472.CAN-03-3675.
535 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
536 Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol Cell Endocrinol. 2004 Jun 30;221(1-2):47-55. doi: 10.1016/j.mce.2004.04.010.
537 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
538 SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. Cancer Res. 2006 Feb 15;66(4):2279-86. doi: 10.1158/0008-5472.CAN-05-2057.
539 Selective activation of Src family kinases and JNK by low levels of chromium(VI). Toxicol Appl Pharmacol. 2003 Aug 1;190(3):214-23. doi: 10.1016/s0041-008x(03)00188-1.
540 Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014 Feb 1;87(3):424-34. doi: 10.1016/j.bcp.2013.11.008. Epub 2013 Nov 23.
541 Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells. J Biol Chem. 2015 Jun 19;290(25):15799-15811. doi: 10.1074/jbc.M115.641167. Epub 2015 May 11.
542 Mithramycin inhibits human epithelial carcinoma cell proliferation and migration involving downregulation of Eps8 expression. Chem Biol Interact. 2010 Jan 5;183(1):181-6. doi: 10.1016/j.cbi.2009.09.018.
543 The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol. 2023 Aug;39(4):1561-1575. doi: 10.1007/s10565-022-09747-9. Epub 2022 Aug 12.
544 Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G910-22. doi: 10.1152/ajpgi.90672.2008. Epub 2009 Jan 22.
545 Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model. Pancreas. 2006 Aug;33(2):142-7. doi: 10.1097/01.mpa.0000226882.48204.26.
546 Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res. 2008 Apr 1;68(7):2349-57. doi: 10.1158/0008-5472.CAN-07-5528.
547 Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PLoS One. 2011 Jan 24;6(1):e16331. doi: 10.1371/journal.pone.0016331.
548 Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol. 2016 Apr 26;7:111.
549 Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation. Toxicol Lett. 2017 Nov 5;281:20-25. doi: 10.1016/j.toxlet.2017.08.012. Epub 2017 Aug 24.
550 Activation of PPAR and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 2020 Aug 21;15(8):e0237976. doi: 10.1371/journal.pone.0237976. eCollection 2020.
551 Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar;25(3):771-8. doi: 10.1634/stemcells.2006-0271. Epub 2006 Nov 30.
552 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
553 Transcriptional repression of IKK by p53 in arsenite-induced GADD45 accumulation and apoptosis. Oncogene. 2019 Jan;38(5):731-746. doi: 10.1038/s41388-018-0478-7. Epub 2018 Sep 3.
554 Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ Mol Mutagen. 2007 Apr-May;48(3-4):179-89. doi: 10.1002/em.20245.
555 Small-scale immunopurification of cytochrome c oxidase for a high-throughput multiplexing analysis of enzyme activity and amount. Biotechnol Appl Biochem. 2007 Dec;48(Pt 4):167-78. doi: 10.1042/BA20060223.
556 Enhanced levels of several mitochondrial mRNA transcripts and mitochondrial superoxide production during ethinyl estradiol-induced hepatocarcinogenesis and after estrogen treatment of HepG2 cells. Carcinogenesis. 1998 Dec;19(12):2187-93. doi: 10.1093/carcin/19.12.2187.
557 An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone. Biochem Pharmacol. 2007 Jun 15;73(12):1927-38. doi: 10.1016/j.bcp.2007.03.014. Epub 2007 Mar 20.
558 Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Anticancer Res. 2015 Feb;35(2):767-74.
559 High-throughput data integration of RNA-miRNA-circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity. Nucleic Acids Res. 2015 Mar 11;43(5):2525-34. doi: 10.1093/nar/gkv115. Epub 2015 Feb 17.
560 Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. Endocr Relat Cancer. 2011 Apr 28;18(3):333-45. doi: 10.1530/ERC-10-0262. Print 2011 Jun.
561 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
562 Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. Arthritis Rheum. 2012 Jun;64(6):1780-9. doi: 10.1002/art.34342. Epub 2011 Dec 19.
563 Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res. 2008 Apr;18(2):85-94. doi: 10.1097/CMR.0b013e3282f60097.
564 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
565 Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol. 2001 May 15;61(10):1205-15. doi: 10.1016/s0006-2952(01)00583-4.
566 Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol. 2008 May 15;75(10):1924-34. doi: 10.1016/j.bcp.2008.02.013. Epub 2008 Feb 17.
567 Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells. Anticancer Res. 2003 Jan-Feb;23(1A):267-73.
568 Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA. Cell Mol Immunol. 2007 Feb;4(1):59-63.
569 Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2020 Sep 27;12(10):2774. doi: 10.3390/cancers12102774.
570 Down-regulation of HER-2 expression in human breast cancer cell HBC-4 and ZR75-1 by nitrogen-mustard-N-oxide. Kobe J Med Sci. 2007;53(4):135-42.
571 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
572 Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy. Clin Cancer Res. 2005 Oct 15;11(20):7480-9. doi: 10.1158/1078-0432.CCR-05-0328.
573 Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicol Sci. 2002 Apr;66(2):233-43. doi: 10.1093/toxsci/66.2.233.
574 ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Mol Cancer Ther. 2007 May;6(5):1579-87. doi: 10.1158/1535-7163.MCT-06-0814.
575 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
576 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
577 Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002 Nov 1;62(21):6006-10.
578 Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog. 2006 Oct;45(10):752-63.
579 A genome-wide analysis of targets of macrolide antibiotics in mammalian cells. J Biol Chem. 2020 Feb 14;295(7):2057-2067. doi: 10.1074/jbc.RA119.010770. Epub 2020 Jan 8.
580 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
581 Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol. 2002 Oct;40(4):625-31.
582 Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways. Int J Mol Sci. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039.
583 Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer. Cancer Res. 2010 Feb 15;70(4):1314-22. doi: 10.1158/0008-5472.CAN-09-3292. Epub 2010 Feb 9.
584 PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells. Antioxid Redox Signal. 2002 Dec;4(6):877-84. doi: 10.1089/152308602762197416.
585 Cytokine abnormalities in a patient with eosinophilic fasciitis. Ann Allergy Asthma Immunol. 2003 Apr;90(4):452-5. doi: 10.1016/S1081-1206(10)61832-7.
586 Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracil. Br J Pharmacol. 2009 Jun;157(3):362-70. doi: 10.1111/j.1476-5381.2009.00161.x. Epub 2009 Apr 9.
587 Enhanced apoptosis and transforming growth factor-beta1 expression in colorectal adenomas and carcinomas after Sulindac therapy. Dis Colon Rectum. 2001 Jul;44(7):1008-15. doi: 10.1007/BF02235490.
588 The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures. Toxicol Sci. 2016 Jun;151(2):434-46. doi: 10.1093/toxsci/kfw057. Epub 2016 Mar 29.
589 The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.
590 Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics. 2011 Jan;10(1):M110.002170.
591 Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. J Med Chem. 2017 Feb 23;60(4):1262-1271. doi: 10.1021/acs.jmedchem.6b00990. Epub 2016 Dec 21.